Develop novel disease-modifying therapeutics to treat a broad range of cardiometabolic diseases in humans and companion animals.
We are pioneers in developing long-acting peptide-based therapeutics. We have extensive experience in developing cutting-edge biotech therapies, and we are constantly exploring new ways to improve patient outcomes.
We modify peptide agonists using our proprietary enabling technology to develop long-acting disease-modifying therapeutics for cardiometabolic diseases
We are focused on developing next-generation therapeutics. Subscribe below to receive updates on our progress.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.